Clinical Trial Update: Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining endometrial safety of a low-dose Vagifem in postmenopausal women with atrophic vaginitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Vaginal Atrophy

Drugs mentioned

• Vagifem (Estradiol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Postmenopausal Vaginal Atrophy | Phase 3 | Status: COMPLETED | Results posted: 2011-04-07